DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01777 P3 ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL SARS-CoV-2 32482145
DRAVPe01778 Alisporivir, Debio-025 XxXVXAaXXXX SARS-CoV-2 32376613,32568027
DRAVPe01779 Plitidepsin, Aplidine PxTXXLPX SARS-CoV-2 35231500,33495306
DRAVPe01802 FBP RGAHIKGRWKSRCHRF Influenza A virus, Influenza B virus, SARS-CoV-2 35259078
DRAVPe01821 BPIP LLMVNEATRFQTVSGFV SARS-CoV-2 35896605
DRAVPe01865 PIH CGGGGGSLTEINTELLDLEYEMKKLEEVVKKLEESYIDLKEL MERS-CoV 31099550
DRAVPe01948 Bomidin MGRFKRFRKKFKKLFKKLS DENV, HSV,SARS-CoV-2 35663971
DRAVPe01977 SARS-CoV S (668–679), SP-10 STSQKSIVAYTM SARS-CoV 16337697
DRAVPe01978 SARS-CoV S (192-203), SP-4 GFLYVYKGYQPI SARS-CoV 16337697
DRAVPe01979 SARS-CoV S (483-494), SP-8 FYTTTGIGYQPY SARS-CoV 16337697
DRAVPe01981 Peptide1(ACE2 (21-43)[N13Q,A16V,D18E,L19I,F20Y,Y21W]) IEEQAKTFLDKFQHEVEEIYWQS SARS-CoV-2 34328726
DRAVPe01982 Peptide2 QDKHEEDYQMYNKGDKED SARS-CoV-2 34328726
DRAVPe01983 Peptide3 DKFNHEAEDLFYQSSLASWNYNT SARS-CoV-2 34328726
DRAVPe01984 Peptide4 IDENARSYIDKFQHDAEEMWYQ SARS-CoV-2 34328726
DRAVPe01985 Peptide5 IYALLENAEDYNLVN SARS-CoV-2 34328726
DRAVPe01986 Peptide6 SRDKHEEHEKENDRGQ SARS-CoV-2 34328726
DRAVPe02028 PL8 PSSKRFQPFQQFGRDVSDFTDSVRDPKTSE SARS-CoV 15811330
DRAVPe02029 P10 RNTREVFAQVKQMYKTPTLKYFG SARS-CoV 15811330
DRAVPe02030 P9 CANLLLQYGSFCTQLNRALSGIA SARS-CoV 15811330
DRAVPe02032 BD-11b YKYRYL SARS-CoV 22265858
DRAVPe02040 Surfactin EVLADL PEDV 30973929
DRAVPe02041 SLP1 EVLADLV PEDV 30973929
DRAVPe02042 SLP2 EVLDLV PEDV 30973929
DRAVPe02043 SLP3 EVLDL PEDV 30973929
DRAVPe02044 SLP4 EVLL PEDV 30973929
DRAVPe02045 SLP5 EVLDL PEDV 30973929
DRAVPe02046 SLP6 KVLKL PEDV 30973929
DRAVPe02047 SLP7 EVLDL PEDV 30973929
DRAVPe02048 SLP8 EVLLD PEDV 30973929
DRAVPe02049 SLP9 EDVLL PEDV 30973929
First 5 6 7 8 9 10 11 Last